Developement of minimaly invasive chemoradiotherapy with a method of sentinel lymph node for head and neck cancer

Developement of minimaly invasive chemoradiotherapy with a method of sentinel lymph node for head and neck cancer - Minimaly invasive chemoradiotherapy with sentinel lymph node for head and neck cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007379

Enrollment

Registered

2012-02-25

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

Detect of SLN by 3DCT-LG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients had untreatement head and neck squamous cell carcinoma ( oral, pharynx, larynx, maxillary sinus) and had over T2 disease with deseased side LN metastases for example N1 or N2b. 1,patient age 20years and above 2,histologically daiagnosed SCC 3,adaptation of radical radiation therapy in primary and neck lesion 4,untreatemented case 5,written informed consent

Exclusion criteria

Exclusion criteria: 1,distant metastasis 2,previously treated patients 3,A history of radiation therapy for the neck 4,pregnancy or lactating women or women with suspected pregnancy 5,Patients judged by the investigator to be unfit to be enrolled into the study

Design outcomes

Primary

Measure	Time frame
radiation control rate in nomal side LN and completion rate of radiotherapy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026